Kratom-containing dietary supplement manufacturers and marketers are asking FDA to recant its Nov. 14 consumer advisory about the ingredient, arguing the agency's information is inaccurate and casting the ingredient as a tool in helping curb narcotics abuse.
"The substantial gap between the publicly available evidence showing the safety of kratom, and the secretive and unsubstantiated conclusions of...





